label
Man Walking On Digital Bridge Banner

Welcome to the PDT Pathway—where a new era in mental health has begun

mobile-potriat
Designed to be convenient and user friendly, PDTs are software-based solutions that are authorized by the FDA* and can be incorporated into a multimodal treatment approach.1
tablet icon
Accessible 24/7 on smartphones and tablets, PDTs are clinically proven to help treat, manage, or prevent a spectrum of diseases and disorders.1,3,4

*While drugs are “approved” by the FDA, PDTs are FDA “authorized” or cleared as a software as a medical device (SaMD). All of them are required to have clinical trials as part of the FDA authorization.5

PDTs could help empower your patients to become active stakeholders in their mental health.2,6-9

Discover the benefits of PDTs
woman walking beside a man in a wheelchair

There is a need for an evidence-based treatment modality to help address gaps in mental health care1,7,8

55% of Mental Health Conditions Receive No Treatment

Many people don’t receive the necessary treatment they need.10

Mental Illness Incidence Increased between 2008 & 2022

While incidences of diagnosed mental illness have increased, services remain underutilized.13

60% of People With Mental Health Conditions Chose Not To Get Treatment

A majority of people reported they do not choose to get treatment because they want to address their condition on their own.13

People living with mental health conditions face many challenges13-15

Thumb Down Icon
Stigma

Stigma profoundly influences psychiatric care, creating barriers to the timely recognition and treatment of mental health disorders.14

Group of HCPs Icon
Limited number of healthcare professionals

There are insufficient numbers of mental health professionals, limiting access to treatment.15

Insufficient Finances Icon
Insufficient finances or transportation

~25% of people with mental health conditions reported that financial and transportation barriers were reasons to discontinue treatment.13

Help your patients overcome the barriers they face

Discover PDTs

Boehringer Ingelheim is championing every mind for generations

References

  1. Brezing CA, Brixner DI. The rise of prescription digital therapeutics in behavioral health. Adv Ther. 2022;39(12):5301-5306. doi:10.1007/s12325-022-02320-0

  2. Liesch J, Murphy D. Digital Therapeutics 101: An Introduction and Overview. Blue Matter Consulting. Published 2021. Accessed May 17, 2024. https://bluematterconsulting.com/wp-content/uploads/2021/06/Digital-Therapeutics-101-eBook-06-2021.pdf

  3. Maricich YA, Gerwien R, Kuo A, Malone DC, Velez FF. Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder. Hosp Pract (1995). 2021;49(5):348-355. doi:10.1080/21548331.2021.1974243

  4. Maricich YA, Xiong X, Gerwien R, et al. Real-world evidence for a prescription digital therapeutic to treat opioid use disorder. Curr Med Res Opin. 2021;37(2):175-183. doi:10.1080/03007995.2020.1846023

  5. Watson A, Chapman R, Shafai G, Maricich YA. FDA regulations and prescription digital therapeutics: evolving with the technologies they regulate. Front Digit Health. 2023;5:1086219. doi:10.3389/fdgth.2023.1086219

  6. Fenn K, Byrne M. The key principles of cognitive behavioural therapy. InnovAiT. 2013;6(9):579-585. doi:10.1177/1755738012471029

  7. Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care. 2020;9(5):2207-2213. doi:10.4103/jfmpc.jfmpc_105_20

  8. Jacobson NC, Kowatch T, Marsch LA, eds. Digital Therapeutics for Mental Health and Addiction: The State of the Science and Vision for the Future. Academic Press; 2023.

  9. Unnikrishnan AG, Viswanathan V, Zhou FL, et al. Impact of My Dose Coach app frequency of use on clinical outcomes in type 2 diabetes. Diabetes Ther. 2022;13(5):983-993. doi:10.1007/s13300-022-01245-9

  10. National Alliance on Mental Illness. Mental health by the numbers. Updated April 2023. Accessed August 21, 2024. https://www.nami.org/about-mental-illness/mental-health-by-the-numbers/

  11. Substance Abuse and Mental Health Services Administration. Results from the 2020 National Survey on Drug Use and Health: detailed tables, SAMHSA, CBHSQ. Section 10. Accessed August 21, 2024. https://www.samhsa.gov/data/sites/default/files/reports/rpt35323/NSDUHDetailedTabs2020v25/NSDUHDetailedTabs2020v25/NSDUHDetTabsSect10pe2020.htm

  12. Substance Abuse and Mental Health Services Administration. Results from the 2022 National Survey on Drug Use and Health: detailed tables, SAMHSA, CBHSQ. Section 6. Accessed August 21, 2024. https://www.samhsa.gov/data/sites/default/files/reports/rpt42728/NSDUHDetailedTabs2022/NSDUHDetailedTabs2022/NSDUHDetTabsSect6pe2022.htm

  13. Andrade LH, Alonso J, Mneimneh Z, et al. Barriers to mental health treatment: results from the WHO World Mental Health surveys. Psychol Med. 2014;44(6):1303-1317. doi:10.1017/S0033291713001943

  14. Ahad AA, Sanchez-Gonzalez M, Junquera P. Understanding and addressing mental health stigma across cultures for improving psychiatric care: a narrative review. Cureus. 2023;15(5):e39549. doi:10.7759/cureus.39549

  15. Hoffmann JA, Attridge MM, Carroll MS, Simon NE, Beck AF, Alpern ER. Association of youth suicides and county-level mental health professional shortage areas in the US. JAMA Pediatr. 2023;177(1):71-80. doi:10.1001/jamapediatrics.2022.4419